Cross-species analysis of genetically engineered mouse models of MAPK-driven colorectal cancer identifies hallmarks of the human disease
Effective treatment options for advanced colorectal cancer (CRC) are limited, survival rates are poor and this disease continues to be a leading cause of cancer-related deaths worldwide. Despite being a highly heterogeneous disease, a large subset of individuals with sporadic CRC typically harbor re...
Main Authors: | Peter J. Belmont, Eva Budinska, Ping Jiang, Mark J. Sinnamon, Erin Coffee, Jatin Roper, Tao Xie, Paul A. Rejto, Sahra Derkits, Owen J. Sansom, Mauro Delorenzi, Sabine Tejpar, Kenneth E. Hung, Eric S. Martin |
---|---|
Format: | Article |
Language: | English |
Published: |
The Company of Biologists
2014-06-01
|
Series: | Disease Models & Mechanisms |
Subjects: | |
Online Access: | http://dmm.biologists.org/content/7/6/613 |
Similar Items
-
Genetic Mutations of Pancreatic Cancer and Genetically Engineered Mouse Models
by: Yuriko Saiki, et al.
Published: (2021-12-01) -
CRAF dimerization with ARAF regulates KRAS-driven tumor growth
by: Avinashnarayan Venkatanarayan, et al.
Published: (2022-02-01) -
Unraveling the Oncogenic Potential of VAV1 in Human Cancer: Lessons from Mouse Models
by: Batel Shalom, et al.
Published: (2023-04-01) -
Differential Effects of Trp53 Alterations in Murine Colorectal Cancer
by: Alexander M. Betzler, et al.
Published: (2021-02-01) -
The Molecular Pathology of Odontogenic Tumors: Expanding the Spectrum of MAPK Pathway Driven Tumors
by: Letícia Martins Guimarães, et al.
Published: (2021-09-01)